(Press-News.org) (MEMPHIS, Tenn., April 29, 2024)- Hongbo Chi, PhD, a faculty member and the Robert G. Webster Endowed Chair in Immunology at St. Jude Children’s Research Hospital, has been recognized as a fellow of the American Association for the Advancement of Science (AAAS), the world’s largest general scientific society and publisher of the Science Family of Journals. Chi will be formally inducted Sept. 21, during the organization’s annual Fellows Forum in Washington D.C.
Chi is the most recent St. Jude faculty member selected as an AAAS Fellow. Other St. Jude honorees include: Thirumala-Devi Kanneganti, PhD, Victor Torres, PhD, Douglas Green, PhD, Charles Rock, PhD, Mary Relling, PharmD, Guillermo Oliver, PhD, Charles Sherr, MD, PhD, James Downing, MD, Peter Doherty, PhD, Ching Hon Pui, MD, Joesph Simone, MD and William Evans, PharmD.
“I am deeply honored to be named a Fellow of such a prestigious organization,” said Chi, who will be the 13th St. Jude faculty member to become an AAAS Fellow. “This recognition highlights the work we do at St. Jude that is changing the field of immunology and advancing immunometabolism and systems immunology.”
AAAS elects members annually whose efforts on behalf of the advancement of science, or its applications, are scientifically or socially distinguished. Chi’s selection is based on his contributions to immunology and immunometabolism, especially T-cell metabolism and systems immunology. This work has led to a deeper understanding of the interplay between metabolism and immunity, such as nutrient effects on immune responses and metabolic reprogramming of cell fate.
Since joining St. Jude in 2007, Chi has focused on immunology, or the biology of the immune system, specifically how cell metabolism and nutrient signaling control the function of T cells. These cells are the center of adaptive immunity and are crucial components in fighting cancer and infectious diseases. Chi’s lab has performed pioneering research in immunometabolism, including establishing metabolic reprogramming of cell fate and state and defining mTOR and metabolic checkpoints in immune function and disease. His more recent studies, using in vivo high-throughput perturbation screening, multi-omics and other unbiased approaches to investigate T cell metabolism and immune system functions, have revealed novel metabolic drivers and regulatory networks and their impacts on adaptive immunity in cancer, autoimmunity and neurodegenerative diseases. These seminal discoveries have contributed to the fundamental knowledge in immunology, and moreover, the identification of actionable disease targets has established clear paths to clinical translation (e.g., targeting the enzyme REGNASE-1 is being translated into next-generation CAR T-cell therapies for cancer).
His work is widely referenced, earning him a place on the lists of Highly Cited Researchers in immunology by the Institute for Scientific Information at Clarivate for four years continuously. He has received an outstanding investigator award and a merit award from NIH, Dr. William E. Paul Distinguished Innovator Award from Lupus Research Alliance, and Alumni Achievement Award from the University of Rochester. Originally from China, he earned his PhD in pathology from the University of Rochester in Rochester, New York. He performed his postdoctoral training in immunobiology at Yale University in New Haven, Connecticut.
“Dr. Chi's contributions to the scientific community are helping children with catastrophic diseases everywhere," said James R. Downing, M.D., St. Jude president and CEO. "Other researchers and clinicians are building on his work, especially in the field of immunology, to find new ways to treat patients and improve their overall quality of life.”
Dating back to 1874, election as an AAAS Fellow is a lifetime honor. Fellows are expected to maintain the highest standards of professional ethics and scientific integrity. Distinguished honorees include: W.E.B DuBois, Ellen Ochoa, Steven Chu, Grace Hopper, Alan Alda, Mae Jemison and Ayanna Howard.
St. Jude Media Relations Contacts
Michael Sheffield
Desk: (901) 595-0221
Cell: (901) 379-6072
michael.sheffield@stjude.org
media@stjude.org
Rae Lyn Hartley
Cell: (901) 686-2597
raelyn.rushing@stjude.org
media@stjude.org
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is leading the way the world understands, treats and cures childhood cancer, sickle cell disease, and other life-threatening disorders. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20% to 80% since the hospital opened more than 60 years ago. St. Jude shares the breakthroughs it makes to help doctors and researchers at local hospitals and cancer centers around the world improve the quality of treatment and care for even more children. To learn more, visit stjude.org, read Progress: A Digital Magazine, and follow St. Jude on social media at @stjuderesearch.
###
END
WINSTON-SALEM, N.C. – April 29, 2024 – A new study from researchers at Wake Forest University School of Medicine shows that school entry requirements are linked to an increase in human papillomavirus (HPV) vaccinations.
The findings appear online in Pediatrics.
HPV is a common sexually transmitted infection, which can cause health problems such as genital warts and certain cancers. To prevent infection, the Centers for Disease Control and Prevention (CDC) recommend that 11- to 12-year-olds receive two doses of the HPV vaccine, given 6 to 12 months apart. However, CDC data from 2022 ...
A study published Monday in the Journal of Urban Health by a team of CUNY researchers finds that food delivery gig workers in New York City face a high risk of injury and assault, particularly those dependent on gig work as their main job. The study analyzes data from a survey of 1,650 delivery workers, collected between October and December 2021 by the New York City Department of Consumer and Worker Protection.
Alarmingly, about 22% reported experiencing injuries, and 21% reported assaults while on the job, with those using e-bikes or mopeds more than twice as likely to be injured or assaulted compared to those who deliver by car.
Of particular importance was the relationship ...
Researchers at UNC Lineberger Comprehensive Cancer Center, after decades of research efforts, have developed a mouse model of Kaposi sarcoma that could be key to the development of new drugs to treat the disease. Kaposi sarcoma is a cancer that is the most common cancer in people living with HIV.
The findings appeared in Cell Host & Microbe.
“This is an important development as we have created the first animal model ever of Kaposi sarcoma. Animal models are essential to move new drugs from the laboratory bench into clinical trials,” said UNC Lineberger’s Dirk Dittmer, PhD, senior corresponding author, co-leader of the UNC Lineberger Virology ...
The relationship between living in a polluted city like São Paulo (Brazil) and lung disease or cancer is well known. But the problems go further. Unprecedented research shows that long-term exposure to air pollution is directly linked to increased heart risks in residents of the capital of the state of the same name. People with high blood pressure are at even greater risk.
The study, published in the journal Environmental Research, was conducted by researchers from the University of São Paulo (USP) with support from FAPESP (projects 13/21728-2, 16/23129-7 and 19/06435-5). The research shows ...
Rice University bioscientist Yousif Shamoo has been elected a fellow of the American Association for the Advancement of Science (AAAS), the world’s largest general scientific society and publisher of the journal Science.
The lifetime honor, one of the highest in the scientific community, is accorded to fewer than 1% of AAAS members each year. Shamoo, the Ralph and Dorothy Looney Professor in the Department of Biosciences, was recognized “for distinguished contributions to research on multidrug resistance, protein structure ...
Igor Mazin, Professor of Practice for Advanced Studies in Theoretical Physics, Quantum Materials Center, Physics and Astronomy, is set to receive funding for the project: “Electronic, transport and topological properties of frustrated magnets.”
In this project, Mazin and his collaborators will examine frustrated magnetic systems.
Magnetic frustration lies at the core of the notion of skyrmions and quantum spin liquid.
Mazin will receive $258,480 from the National Science Foundation for this project. Funding will begin in May 2024 and will end in late April 2027.
###
ABOUT GEORGE MASON UNIVERSITY
George Mason University is Virginia’s largest ...
NEW YORK – April 25, 2024 – The TCT® 2024 Career Achievement Award will be presented to Robert A. Harrington, MD, during Transcatheter Cardiovascular Therapeutics® (TCT®), the annual scientific symposium of the Cardiovascular Research Foundation® (CRF®). TCT® will take place October 27-30 2024, in Washington, DC at the Walter E. Washington Convention Center. The award is given each year to an outstanding individual who has made extraordinary contributions to the field of interventional cardiology and has transformed ...
The Tibetan plateau—the world’s highest and largest plateau—poses a challenge to the people who live there because of its extreme climate. In a new study, researchers have discovered stone artifacts that suggest that there were more cultural exchanges between those who lived on the plateau and those living on its perimeter.
“The Tibetan plateau has an average elevation of more than 4500 meters, which makes Colorado seem like it is at sea level. It’s amazing that people have been able to occupy this area on and off for at least the last 40,000 years,” said Stanley Ambrose (MME), a professor of anthropology. “Unfortunately, very little ...
Oncotarget is a contributing sponsor at the 19th International p53 Workshop in Trieste, Italy, on May 13–16, 2024.
BUFFALO, NY- April 29, 2024 – Oncotarget is a contributing sponsor at the 19th International p53 Workshop, organized by the International Center for Genetic Engineering and Biotechnology (ICGEB), which takes place from May 13–16, 2024, in Trieste, Italy.
“Groundbreaking research and cutting-edge advancements in the field of the most studied human gene and most frequently mutated gene in cancer, will take center stage at the 19th ...
ITHACA, N.Y. -- New York state solar construction workers – whose numbers are expected to grow rapidly to meet climate goals – are transient, may not receive benefits and are subject to racial disparities in pay, finds a new report from the Climate Jobs Institute (CJI) at Cornell University.
“Exploring the Conditions of the New York Solar Workforce” was funded by the New York State Department of Labor and surveyed more than 260 solar installation and maintenance workers. The exploratory study is the first to focus on workers’ experiences, seeking to bridge gaps in government and industry ...
